Founded in 2015, Zumutor Biologics operates in Health Tech industry. Initially targeting immune-oncology innovations, the company has significantly broadened its research and drug development pursuits...
Funding stage:
Series B
Last funding:
12/06/2026
Total funding:
$29.00 Mn+
Revenue:
Investors
Employee count:
25
Last 90d
25
Last 90d
Web traffic:
6.67K
6.67K
Last 30d
Last 30d
Glassdoor Rating:
Zumutor Biologics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders8
Latest Filing Date29 April 2025- Funding Events20
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Zumutor Biologics
As of 30 April 2025, Zumutor Biologics's equity is held by 8 shareholders, with the top three being Zumutor, Bharat Innovation Fund, and Deep Science India Fund.
Zumutor holds the largest stake in Zumutor Biologics at 83.3% as of 30 April 2025.
As of 30 April 2025, founders collectively hold 0.0% equity in Zumutor Biologics.
As of 30 April 2025, investors collectively hold 16.7% equity in Zumutor Biologics.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links